HGF binds to its receptor c-Met to activate pathways such as phosphoinositide 3-kinase–protein kinase B, thereby alleviating insulin resistance, enhancing glucose homeostasis, promoting angiogenesis, and inhibiting fibrosis [26,27]. The gene discussed is MET; the disease is Insulin resistance.